United StatesThe article discusses recent developments in biotechnology, including a syphilis drug shortage affecting pregnant women in Arizona, the FDA's approval of Sanofi's diabetes drug Tzield following a contentious review, and the Trump administration's proposal to close a Medicare negotiation loophole.
Bias read (Center): The article presents factual updates on biotech-related issues without overtly favoring any political side. It mentions policy proposals from the Trump administration but does not provide commentary or framing that suggests a particular ideological leaning.
